CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Nov. 30, 2019	Nov. 30, 2018	Nov. 30, 2017
Cash flows from operating activities:
Net income	$ 500,712	$ 299,981	$ 300,240
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	372,108	225,287	159,886
Share-based compensation	27,959	22,678	17,368
Provision for doubtful accounts	34,911	7,246	8,268
Excess tax benefit from share-based compensation			(5,546)
Deferred income taxes	(18,189)	(47,072)	(25,916)
Contingent consideration	(19,034)
Unrealized foreign exchange (gains) losses	1,521	8,867	(3,542)
Convertible debt conversion option fair value and extinguishment (gains) losses	1,559	(9,996)
Other	9,719	(2,310)	4,861
Changes in operating assets and liabilities, net of acquisition of businesses:
Accounts receivable, net	(326,681)	(451,188)	(376,371)
Receivables from vendors, net	(26,389)	(63,831)	(83,477)
Inventories	(153,134)	(366,392)	(261,423)
Accounts payable	98,392	381,970	341,962
Other operating assets and liabilities	46,465	95,466	100,454
Net cash provided by operating activities	549,919	100,706	176,764
Cash flows from investing activities:
Purchases of investments		(66)	(12,942)
Proceeds from maturity of held-to-maturity investments		5,680	10,625
Proceeds from sale of trading investments		12,893
Purchases of property and equipment	(137,423)	(125,305)	(97,546)
Acquisition of businesses, net of cash acquired and refunds	(9,427)	(1,069,946)	(526,658)
Purchase of non-marketable equity security investments			(30,000)
Other	13	(2,848)	2,264
Net cash used in investing activities	(146,837)	(1,179,592)	(654,257)
Cash flows from financing activities:
Proceeds from borrowings, net of debt discount and issuance costs ($22, $9,187 and $4,400 in fiscal years ended November 30, 2019, 2018 and 2017, respectively)	7,503,576	10,060,449	9,061,771
Repayments of borrowings	(8,024,961)	(8,930,165)	(8,382,379)
Dividends paid	(76,607)	(59,720)	(41,815)
Excess tax benefit from share-based compensation			5,546
Increase (decrease) in book overdraft	(1,908)	(1,028)	1,166
Repurchases of common stock	(15,184)	(65,987)
Proceeds from issuance of common stock	5,367	4,924	4,236
Repurchases of common stock for tax withholdings on equity awards	(7,911)	(6,413)	(9,871)
Settlement of contingent consideration	(13,966)
Other	(107)	(914)
Net cash provided by (used in) financing activities	(631,701)	1,001,146	638,654
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(2,265)	(16,969)	8,414
Net increase (decrease) in cash, cash equivalents and restricted cash	(230,884)	(94,709)	169,575
Cash, cash equivalents and restricted cash at beginning of year	462,033	556,742	387,167
Cash, cash equivalents and restricted cash at end of year	231,149	462,033	556,742
Supplemental disclosures of cash flow information:
Interest paid on borrowings	156,261	88,645	36,783
Income taxes paid	236,493	144,705	136,805
Supplemental disclosure of non-cash investing activities:
Fair value of common stock issued for acquisition of business		1,017,329
Accrued costs for property and equipment purchases	$ 10,117	$ 4,186	$ 2,239